NPFCX
Price
$69.50
Change
-$0.03 (-0.04%)
Updated
Sep 2 closing price
Net Assets
165.87B
RNGAX
Price
$70.69
Change
+$0.11 (+0.16%)
Updated
Sep 2 closing price
Net Assets
48.72B
Interact to see
Advertisement

NPFCX vs RNGAX

NPFCX vs RNGAX Comparison Chart in %
View a ticker or compare two or three
VS
NPFCX vs. RNGAX commentary
Sep 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NPFCX is a StrongBuy and RNGAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NPFCX has more cash in the bank: 166B vs. RNGAX (48.7B). NPFCX pays higher dividends than RNGAX: NPFCX (0.33) vs RNGAX (0.00). NPFCX was incepted earlier than RNGAX: NPFCX (25 years) vs RNGAX (24 years). RNGAX (1.49) and NPFCX (1.47) have similar cost to investors . RNGAX is a more actively managed with annual turnover of: 36.00 vs. NPFCX (23.00). NPFCX (250) and RNGAX (250) have matching initial minimum investment requirements. RNGAX annual gain was more profitable for investors over the last year : 19.96 vs. NPFCX (6.14). RNGAX return over 5 years is better than : 16.59 vs. NPFCX (5.03).
NPFCXRNGAXNPFCX / RNGAX
Total Expense Ratio1.471.4999%
Annual Report Gross Expense Ratio1.471.4999%
Fund Existence25 years24 years-
Gain YTD6.09117.25035%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets166B48.7B341%
Annual Yield % from dividends0.330.00-
Returns for 1 year6.1419.9631%
Returns for 3 years34.4254.6263%
Returns for 5 years5.0316.5930%
Returns for 10 years94.27103.8991%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FRBRX221.27N/A
N/A
Franklin Biotechnology Discovery R6
VSGAX121.15N/A
N/A
Vanguard MStar Small Cap Growth Idx Adm
LSVGX21.55N/A
N/A
LSV Global Value Institutional
PRJQX37.36N/A
N/A
PGIM Jennison Global Opportunities R6
VYGLX12.96N/A
N/A
Voya Global Income & Growth I